Toposar (Teva Parenteral Medicines, Inc.)


Welcome to the PulseAid listing for the Toposar drug offered from Teva Parenteral Medicines, Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Parenteral Medicines, Inc.
NON-PROPRIETARY NAME: Etoposide
SUBSTANCE NAME: ETOPOSIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1996-08-01
END MARKETING DATE: 0000-00-00


Toposar HUMAN PRESCRIPTION DRUG Details:

Item DescriptionToposar from Teva Parenteral Medicines, Inc.
LABELER NAME: Teva Parenteral Medicines, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 1996-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0703-5653_7e4d6274-b5fc-4d26-8911-78214a237a04
PRODUCT NDC: 0703-5653
APPLICATION NUMBER: ANDA074529

Other ETOPOSIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Etoposide
BluePoint LaboratoriesEtoposide
Fresenius Kabi USA, LLCEtoposide
Mylan Pharmaceuticals Inc.Etoposide
Teva Parenteral Medicines, Inc.Toposar
ThyMoorgan GmbH Pharmazir & Co. K.GEtoposide
West-Ward Pharmaceuticals CorpEtoposide